Publications While At Healthpartners
Liraglutide and renal outcomes in type 2 diabetes
New England Journal of Medicine.
Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial
Map of science